The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127079471 12707947 1 I 20160822 20160901 20160901 EXP US-PFM-US-2016-2552 PIERRE FABRE MEDICAMENT MILGROM SA, NIETO Y, PINNIX CC, SMITH GL, WOGAN CF, ET ALL. GRAFT-VERSUS-HOST DISEASE AFTER RADIATION THERAPY IN PATIENTS WHO HAVE UNDERGONE ALLOGENEIC STEM CELL TRANSPLANTATION: TWO CASE REPORTS. JOURNAL OF MEDICAL CASE REPORTS 37.00 YR M Y 0.00000 20160829 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127079471 12707947 1 PS VINORELBINE INN VINORELBINE TARTRATE 1 Unknown UNK U 20388
127079471 12707947 2 SS GEMCITABINE GEMCITABINEGEMCITABINE HYDROCHLORIDE 1 Unknown U 0
127079471 12707947 3 C Doxorubicin DOXORUBICIN 1 Unknown U 0
127079471 12707947 4 C BLEOMYCIN BLEOMYCIN SULFATE 1 Unknown U 0
127079471 12707947 5 C Vinblastin VINBLASTINE 1 Unknown U 0
127079471 12707947 6 C DACARBAZINE. DACARBAZINE 1 Unknown UNK U 0
127079471 12707947 7 C IFOSFAMIDE. IFOSFAMIDE 1 Unknown U U 0
127079471 12707947 8 C CARBOPLATIN. CARBOPLATIN 1 Unknown UNK U U 0
127079471 12707947 9 C ETOPOSIDE. ETOPOSIDE 1 Unknown U U 0
127079471 12707947 10 C Brentuximab BRENTUXIMAB VEDOTIN 1 Unknown UNK U U 0
127079471 12707947 11 C Bendamustine BENDAMUSTINE 1 Unknown UNK U U 0
127079471 12707947 12 C Everolimus EVEROLIMUS 1 Unknown U U 0
127079471 12707947 13 C SIROLIMUS. SIROLIMUS 1 Unknown U U 0
127079471 12707947 14 C Vorinostat VORINOSTAT 1 Unknown UNK U U 0
127079471 12707947 15 C Lenalidomide LENALIDOMIDE 1 Unknown UNK U U 0
127079471 12707947 16 C DEXAMETHASONE. DEXAMETHASONE 1 Unknown UNK U U 0
127079471 12707947 17 C CYTARABINE. CYTARABINE 1 Unknown UNK U U 0
127079471 12707947 18 C CISPLATIN. CISPLATIN 1 Unknown U U 0
127079471 12707947 19 C Fludarabin FLUDARABINE PHOSPHATE 1 Unknown UNK U 0
127079471 12707947 20 SS Melphalan MELPHALAN 1 Unknown UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127079471 12707947 1 Hodgkin's disease
127079471 12707947 2 Hodgkin's disease
127079471 12707947 3 Hodgkin's disease
127079471 12707947 4 Hodgkin's disease
127079471 12707947 5 Hodgkin's disease
127079471 12707947 6 Hodgkin's disease
127079471 12707947 7 Hodgkin's disease
127079471 12707947 8 Hodgkin's disease
127079471 12707947 9 Hodgkin's disease
127079471 12707947 10 Hodgkin's disease
127079471 12707947 11 Hodgkin's disease
127079471 12707947 12 Hodgkin's disease
127079471 12707947 13 Hodgkin's disease
127079471 12707947 14 Hodgkin's disease
127079471 12707947 15 Hodgkin's disease
127079471 12707947 16 Hodgkin's disease
127079471 12707947 17 Hodgkin's disease
127079471 12707947 18 Hodgkin's disease
127079471 12707947 19 Hodgkin's disease
127079471 12707947 20 Hodgkin's disease

Outcome of event

Event ID CASEID OUTC COD
127079471 12707947 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127079471 12707947 Graft versus host disease
127079471 12707947 Off label use
127079471 12707947 Product use issue

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found